Pulmonary Alveolar Proteinosis: Rethinking Surfactant Homeostasis Through Alveolar Macrophage Lipid-Handling Dysfunction
Arteriosclerosis, Thrombosis, and Vascular Biology · 2026
DOI: 10.1161/atvbaha.126.322488 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Elinor Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine (E.L.), University of California, Los Angeles. Hauptthemen laut MEDLINE: Pulmonary Alveolar Proteinosis, Macrophages, Alveolar, Pulmonary Surfactants, Lipid Metabolism. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Pulmonary alveolar proteinosis is a rare lung disease characterized by the accumulation of surfactant lipids and proteins within the alveolar space, leading to impaired gas exchange and progressive respiratory dysfunction. In most cases, pulmonary alveolar proteinosis arises from disruption of GM-CSF (granulocyte-macrophage colony-stimulating factor) signaling, resulting in defective alveolar macrophage maturation and a failure of surfactant clearance. Emerging work has reframed pulmonary alveolar proteinosis as a disorder of macrophage lipid handling, linking impaired cholesterol efflux and surfactant catabolism to both disease initiation and progression. In this review, we synthesize current understanding of pulmonary alveolar proteinosis pathophysiology, highlighting GM-CSF–dependent regulation of alveolar macrophage function, insights from animal and cellular models, and the evolving therapeutic landscape. We further discuss how targeting macrophage lipid homeostasis may offer new disease-modifying strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine (E.L.), University of California, Los Angeles.
- Division of Pulmonary, Critical Care, and Sleep Section, VA Greater Los Angeles Healthcare System, CA (E.L.).
- Molecular Biology Institute (I.J.L., E.J.T.), University of California, Los Angeles.
- David Geffen School of Medicine at UCLA, and Division of Cardiology, Department of Medicine (I.J.L., E.J.T.), University of California, Los Angeles.
- School of Medicine, University College Dublin, Ireland (L.D.).
- Jonsson Comprehensive Cancer Center (E.J.T.), University of California, Los Angeles.
ORCID-Profile: Elinor Lee, Isaiah J Little, Elizabeth J Tarling
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Lee, E., Little, I. J., Dantas, L., & Tarling, E. J. (2026). Pulmonary Alveolar Proteinosis: Rethinking Surfactant Homeostasis Through Alveolar Macrophage Lipid-Handling Dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.126.322488
Vancouver
Lee E, Little IJ, Dantas L, Tarling EJ. Pulmonary Alveolar Proteinosis: Rethinking Surfactant Homeostasis Through Alveolar Macrophage Lipid-Handling Dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.126.322488
BibTeX
@article{Lee2026,
author = {Lee, Elinor and Little, Isaiah J and Dantas, Lucas and Tarling, Elizabeth J},
title = {Pulmonary Alveolar Proteinosis: Rethinking Surfactant Homeostasis Through Alveolar Macrophage Lipid-Handling Dysfunction},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2026},
doi = {10.1161/atvbaha.126.322488}
}
EUVIMED